e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Galectin Therapeutics Inc. - Common Stock (NQ:GALT)

3.725 -0.155 (-4.01%)

Streaming Delayed Price Updated: 11:41 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Galectin Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

December 19, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Which stocks are moving on Friday? ↗

December 19, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Why Did GALT Shares Plummet Over 30% Today? ↗

December 19, 2025

Via Stocktwits

Which stocks are gapping on Friday? ↗

December 19, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Galectin Therapeutics: Q3 Earnings Insights ↗

November 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 15, 2025

Via Benzinga

Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

September 25, 2025

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. (NASDAQ: SFIX) dipped 7.6% to $5.21 in pre-market trading following the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 15, 2025

Via Benzinga

Galectin Beats Q2 Loss Estimates ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 20, 2025

Via Benzinga

These stocks are moving in today's session ↗

June 20, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 18, 2025

Via Benzinga

These stocks are moving in today's session ↗

June 17, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 17, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

June 17, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 20, 2024

Via Benzinga

Dow Surges Over 600 Points, Gold Jumps 1.5% ↗

December 20, 2024

Via Benzinga

Topics Stocks

Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher ↗

December 20, 2024

Via Benzinga

Dow Surges 100 Points, Carnival Earnings Top Views ↗

December 20, 2024

Via Benzinga

Topics Stocks

Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday? ↗

December 20, 2024

Galectin Therapeutics' NAVIGATE trial shows belapectin reduces varices in MASH cirrhosis, but falls short of statistical targets; full data due in early 2025.

Via Benzinga

GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024 ↗

August 13, 2024

GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying ↗

July 24, 2024

Via Benzinga

GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024 ↗

May 15, 2024

GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying ↗

April 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 05, 2024

Via Benzinga

GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023 ↗

April 05, 2024

GALT stock results show that Galectin Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗

March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

Via The Motley Fool

More Personal Portfolio: Biotech, Commodities, And Gold ↗

September 24, 2023

In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole.

Via Talk Markets

Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying ↗

July 21, 2023

The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy